Peri‑operative INR Management and Vitamin K Use in Patients on Warfarin

Elective Surgery

Warfarin should be discontinued 5 days before an elective operation; this results in an INR ≤ 1.5 in approximately 93 % of patients. 2
INR should be re‑checked 1–2 days prior to the procedure to verify adequate decline. 1, 2
Target INR ≤ 1.5 for most major surgeries; for very high‑risk procedures (e.g., neurosurgery, neuraxial anesthesia) the goal is INR ≤ 1.2. 3, 4
If the INR remains > 1.5 on the day before surgery despite the 5‑day interruption, give low‑dose oral vitamin K (1–2.5 mg). 1, 5
Oral vitamin K is preferred over the intravenous route in elective settings because it carries a lower risk of anaphylactoid reactions. 3, 4
High‑dose vitamin K (> 5 mg) should be avoided in elective cases, as it may produce postoperative warfarin resistance. 6, 5
The 2022 ACCP guideline recommends against routine pre‑operative vitamin K for an elevated INR measured 1–2 days before surgery; this is a conditional recommendation with very low‑certainty evidence. 7

For immediate reversal, administer a 4‑factor prothrombin complex concentrate (PCC) together with 5 mg intravenous vitamin K. 3, 4, 8
PCC lowers the INR within about 3 minutes, enabling prompt surgical intervention. 3, 4
Vitamin K is required to sustain INR correction beyond 4 hours because the effect of PCC is transient. 3, 4
Target INR < 1.5 for most emergency procedures; aim for INR ≤ 1.2 for neurosurgical or neuraxial cases. 3, 4
When surgery can be delayed 6–12 hours (semi‑urgent), give 5–10 mg intravenous vitamin K. 3, 4, 8
A 5 mg IV dose typically achieves INR < 1.5 within 6–12 hours. 3, 4
A 10 mg IV dose provides faster correction but may postpone postoperative re‑anticoagulation. 3, 4
Vitamin K alone is insufficient for life‑threatening bleeding; PCC must be used. 8

Low‑bleeding‑risk procedures (e.g., dental work, cataract surgery, minor dermatologic interventions) may be performed without stopping warfarin if the INR is within the therapeutic range; INR verification is still advised. 3
High‑bleeding‑risk surgeries require INR measurement and correction to ≤ 1.5 before the operation. 3, 4
Even an INR of 1.0–1.49 carries a higher bleeding risk than an INR < 1.0 in major surgery. 3, 4
For very high‑bleeding‑risk operations (neurosurgery, neuraxial techniques), the target INR is ≤ 1.2. 3, 4, 1, 9

Do not use fresh frozen plasma for routine warfarin reversal; PCC is more effective, faster, and avoids transfusion‑related complications. 3, 4
Avoid routine high‑dose vitamin K (> 5 mg) in elective settings to prevent warfarin resistance and delayed re‑anticoagulation. 6, 5
Do not rely on vitamin K alone for emergency surgery; PCC is required for immediate INR correction. 3, 4, 8
Always obtain a post‑reversal INR measurement after PCC administration to confirm the target has been reached and to guide any additional dosing. 3, 4

Patients at very high thrombotic risk (e.g., mechanical mitral valve, recent thromboembolism) should receive therapeutic‑dose heparin or low‑molecular‑weight heparin during warfarin interruption, but appropriate INR management before surgery remains essential. 6, 2, 10